Costamare Inc. (NYSE:CMRE – Get Free Report) saw a significant growth in short interest in the month of September. As of September 15th, there was short interest totalling 2,620,000 shares, a growth of 5.2% from the August 31st total of 2,490,000 shares. Currently, 6.1% of the company’s stock are sold short. Based on an average daily volume of 520,700 shares, the days-to-cover ratio is presently 5.0 days.
Wall Street Analysts Forecast Growth
CMRE has been the subject of several recent research reports. Jefferies Financial Group increased their price objective on shares of Costamare from $12.00 to $13.00 and gave the company a “hold” rating in a research report on Wednesday, July 31st. StockNews.com raised shares of Costamare from a “hold” rating to a “buy” rating in a report on Friday, August 23rd. Finally, Stifel Nicolaus boosted their price objective on shares of Costamare from $12.00 to $14.00 and gave the stock a “hold” rating in a report on Wednesday, July 24th.
View Our Latest Report on Costamare
Institutional Investors Weigh In On Costamare
Costamare Price Performance
CMRE opened at $15.42 on Wednesday. The company has a quick ratio of 1.54, a current ratio of 1.61 and a debt-to-equity ratio of 0.77. The company’s 50-day moving average price is $14.08 and its 200 day moving average price is $13.89. Costamare has a fifty-two week low of $8.54 and a fifty-two week high of $17.58. The firm has a market cap of $1.81 billion, a price-to-earnings ratio of 5.98 and a beta of 1.37.
Costamare (NYSE:CMRE – Get Free Report) last announced its quarterly earnings results on Wednesday, July 31st. The shipping company reported $0.77 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.72 by $0.05. Costamare had a return on equity of 13.63% and a net margin of 19.63%. The business had revenue of $515.42 million for the quarter, compared to the consensus estimate of $380.41 million. As a group, sell-side analysts expect that Costamare will post 3.05 earnings per share for the current year.
Costamare Company Profile
Featured Stories
- Five stocks we like better than Costamare
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Why Lennar Stock Could Be the Best Play in the Housing Market
- 10 Best Airline Stocks to Buy
- 2 Energy Stocks Fueling the AI Datacenter Boom
- Top Biotech Stocks: Exploring Innovation Opportunities
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Costamare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Costamare and related companies with MarketBeat.com's FREE daily email newsletter.